Sinopharm Group Co. Ltd Cash Flow Reinvestment Rate
Sinopharm Group Co. Ltd cash flow reinvestment rate. Sinopharm Group Co. Ltd (X2S) has a Cash Flow Reinvestment Rate of 0.01x as of December 2022, reinvesting €767.58 Million (capex €654.69 Million plus investments €112.89 Million) from operating cash flow of €52.39 Billion. Explore Sinopharm Group Co. Ltd (X2S) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sinopharm Group Co. Ltd (2013–2025)
Cash flow reinvestment rate of Sinopharm Group Co. Ltd from 2013 to 2025. Historical reinvestment intensity for Sinopharm Group Co. Ltd across 13 annual periods. Explore Sinopharm Group Co. Ltd (X2S) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Sinopharm Group Co. Ltd Cash Flow Reinvestment Rate by Year (2013–2025)
Sinopharm Group Co. Ltd cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Sinopharm Group Co. Ltd. For the full cash flow conversion analysis, see X2S cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | €1.64 Billion | €14.14 Billion | €1.62 Billion | ▼ -32.2% |
| 2024 | 0.17x | €1.97 Billion | €11.55 Billion | €1.97 Billion | ▲ +24.4% |
| 2023 | 0.14x | €2.36 Billion | €17.17 Billion | €2.34 Billion | ▲ +32.2% |
| 2022 | 0.10x | €2.18 Billion | €20.96 Billion | €2.13 Billion | ▼ -53.5% |
| 2021 | 0.22x | €2.08 Billion | €9.31 Billion | €2.07 Billion | ▲ +29.9% |
| 2020 | 0.17x | €1.92 Billion | €11.15 Billion | €1.90 Billion | ▲ +39.4% |
| 2019 | 0.12x | €2.32 Billion | €18.78 Billion | €2.21 Billion | ▼ -87.9% |
| 2018 | 1.02x | €3.74 Billion | €3.65 Billion | €3.24 Billion | ▲ +18.9% |
| 2017 | 0.86x | €2.76 Billion | €3.21 Billion | €2.12 Billion | ▲ +168.3% |
| 2016 | 0.32x | €2.97 Billion | €9.26 Billion | €1.36 Billion | ▲ +321.2% |
| 2015 | 0.08x | €1.02 Billion | €13.41 Billion | €1.02 Billion | ▼ -71.4% |
| 2014 | 0.27x | €1.48 Billion | €5.56 Billion | €1.45 Billion | ▲ +10.3% |
| 2013 | 0.24x | €1.19 Billion | €4.94 Billion | €1.13 Billion | — |